Angiography Devices Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

Angiography devices include X-ray, CT, and MR angiography systems together with the catheters, guidewires, contrast media, and other consumables used during vascular imaging and interventional procedures. The market is valued at roughly USD 12.89 billion in 2025 and is projected to reach approximately USD 13.2 billion by 2032 under one widely cited forecast, implying a steady mid-single-digit expansion. Demand is concentrated in hospitals and specialty cardiac and vascular centers, where angiography underpins diagnosis, stenting, embolization, and other catheter-based interventions.

• •2025 market size estimated at USD 11.5-12.9 billion depending on source scope.
• •Forecast CAGR in the 5.9%-6.2% range across multiple industry analyses.
• •Systems account for the larger revenue share, while consumables provide recurring revenue.

Cardiovascular disease remains the leading cause of mortality worldwide, driving sustained demand for diagnostic coronary angiography and peripheral vascular imaging. Aging populations in North America, Europe, and parts of Asia are increasing procedure volumes, while the migration of care from open surgery to minimally invasive, image-guided interventions continues to expand clinical indications. Technology upgrades, including flat-panel detectors, 3D and rotational angiography, and AI-assisted image reconstruction, are also accelerating the replacement cycle for installed systems.

• •Rising prevalence of coronary artery disease, stroke, and peripheral vascular disease.
• •Expansion of interventional cardiology, neurovascular, and endovascular procedures.
• •Replacement of older analog and lower-resolution systems with digital flat-panel platforms.

By product, the market splits into angiography systems (X-ray, CT, and MR variants) and consumables, with consumables growing fastest because of their procedure-linked recurring use. By technology, X-ray angiography holds the dominant share, while CT and MR angiography are gaining ground in non-invasive diagnostic applications. North America leads in revenue thanks to high procedure volumes and capital budgets, followed by Europe, while Asia-Pacific is the fastest-growing region as healthcare infrastructure and cardiovascular care access expand in China, India, and Southeast Asia.

• •X-ray angiography remains the largest technology segment; CT and MR angiography are rising.
• •North America holds the leading regional share; Asia-Pacific is the fastest-growing region.
• •Hospitals are the primary end users, with ambulatory surgical centers an emerging segment.

What are the recent trends and outlook?

Near-term growth will be shaped by the rollout of AI-assisted image acquisition and analysis, which reduces radiation dose and shortens procedure times, and by the build-out of hybrid operating rooms that combine surgery and advanced imaging. Emerging-economy expansion, including localized manufacturing in Asia, is expected to improve affordability and access while intensifying price competition. Overall, the market is positioned for steady mid-single-digit annual growth through the early 2030s, reaching roughly USD 15-17 billion by 2030-2032 under prevailing forecasts.

• •AI-enabled image processing and dose optimization are becoming standard purchasing criteria.
• •Hybrid ORs and integration with surgical robotics are expanding clinical use cases.
• •Asia-Pacific local manufacturing and value-tier systems are reshaping price points in emerging markets.